| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.807 | 0.01 | 0.807 | Caspase 9 stimulant | 0.788 0.013 CID_980 | ||
| 0.706 | 0.004 | 0.734 | Superoxide dismutase inhibitor | 0.734 0.004 CID_980 | CID_980 | |
| 0.59 | 0.016 | 0.59 | Aryl hydrocarbon receptor agonist | 0.516 0.022 CID_980 | ||
| 0.575 | 0.012 | 0.575 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.57 0.013 CID_980 | ||
| 0.522 | 0.005 | 0.522 | Breast cancer-resistant protein inhibitor | 0.289 0.008 CID_980 | ||
| 0.52 | 0.004 | 0.52 | Calcium channel activator | 0.484 0.006 CID_980 | ||
| 0.513 | 0.009 | 0.513 | Sigma receptor agonist | 0.495 0.01 CID_980 | ||
| 0.515 | 0.025 | 0.515 | Vasodilator, peripheral | 0.504 0.027 CID_980 | ||
| 0.486 | 0.017 | 0.486 | Vasodilator, coronary | 0.446 0.024 CID_980 | ||
| 0.495 | 0.03 | 0.574 | Calcium channel L-type activator | 0.574 0.009 CID_980 | CID_980 | |
| 0.494 | 0.03 | 0.494 | Thioredoxin glutathione reductase inhibitor | 0.484 0.032 CID_980 | ||
| 0.458 | 0.028 | 0.458 | Caspase 3 stimulant | 0.446 0.031 CID_980 | ||
| 0.463 | 0.038 | 0.623 | Aldehyde oxidase inhibitor | 0.623 0.016 CID_980 | CID_980 | |
| 0.454 | 0.038 | 0.454 | Calpain 2 inhibitor | 0.434 0.045 CID_980 | ||
| 0.493 | 0.083 | 0.556 | Alpha-glucosidase inhibitor | 0.556 0.064 CID_980 | CID_980 | |
| 0.4 | 0.004 | 0.429 | Nitric-oxide synthase stimulant | 0.429 0.003 CID_980 | CID_980 | |
| 0.47 | 0.095 | 0.47 | DNA polymerase beta inhibitor | 0.419 0.112 CID_980 | ||
| 0.46 | 0.088 | 0.46 | Transcription factor inhibitor | 0.403 0.108 CID_980 | ||
| 0.392 | 0.025 | 0.439 | Vasodilator | 0.439 0.017 CID_980 | CID_980 | |
| 0.425 | 0.063 | 0.49 | Histamine release inhibitor | 0.49 0.032 CID_980 | CID_980 | |
| 0.451 | 0.091 | 0.502 | Apoptosis agonist | 0.502 0.074 CID_980 | CID_980 | |
| 0.415 | 0.055 | 0.569 | GABA C receptor rho-3 antagonist | 0.569 0.011 CID_980 | CID_980 | |
| 0.36 | 0.005 | 0.36 | 3C-like protease (Human coronavirus) inhibitor | 0.308 0.01 CID_980 | ||
| 0.396 | 0.04 | 0.494 | 12-Lipoxygenase inhibitor | 0.494 0.022 CID_980 | CID_980 | |
| 0.401 | 0.047 | 0.528 | Streptokinase A inhibitor | 0.528 0.025 CID_980 | CID_980 | |
| 0.419 | 0.067 | 0.454 | 5 Hydroxytryptamine release inhibitor | 0.454 0.049 CID_980 | CID_980 | |
| 0.383 | 0.032 | 0.391 | DNA damaging | 0.391 0.031 CID_980 | CID_980 | |
| 0.35 | 0.005 | 0.408 | Succinate dehydrogenase inhibitor | 0.408 0.004 CID_980 | CID_980 | |
| 0.352 | 0.009 | 0.352 | 5 Hydroxytryptamine 1E antagonist | 0.338 0.013 CID_980 | ||
| 0.367 | 0.025 | 0.604 | Peroxidase inhibitor | 0.604 0.004 CID_980 | CID_980 | |
| 0.345 | 0.004 | 0.354 | Mannose-6-phosphate isomerase inhibitor | 0.354 0.004 CID_980 | CID_980 | |
| 0.361 | 0.022 | 0.414 | Anesthetic general | 0.414 0.015 CID_980 | CID_980 | |
| 0.437 | 0.102 | 0.437 | DNA directed DNA polymerase inhibitor | 0.416 0.109 CID_980 | ||
| 0.349 | 0.015 | 0.349 | Tubulin antagonist | 0.143 0.061 CID_980 | ||
| 0.333 | 0.004 | 0.333 | Calcium antagonist | 0.186 0.015 CID_980 | ||
| 0.379 | 0.05 | 0.42 | 5 Hydroxytryptamine release stimulant | 0.42 0.042 CID_980 | CID_980 | |
| 0.341 | 0.014 | 0.376 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.376 0.009 CID_980 | CID_980 | |
| 0.33 | 0.009 | 0.456 | UDP-glucose 4-epimerase inhibitor | 0.456 0.004 CID_980 | CID_980 | |
| 0.33 | 0.009 | 0.33 | Toll-Like receptor 9 antagonist | 0.245 0.022 CID_980 | ||
| 0.327 | 0.015 | 0.417 | Amylase inhibitor | 0.417 0.008 CID_980 | CID_980 | |
| 0.32 | 0.01 | 0.341 | NADPH oxidase inhibitor | 0.341 0.008 CID_980 | CID_980 | |
| 0.316 | 0.011 | 0.428 | M18 aspartyl aminopeptidase inhibitor | 0.428 0.004 CID_980 | CID_980 | |
| 0.308 | 0.006 | 0.346 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.346 0.005 CID_980 | CID_980 | |
| 0.326 | 0.024 | 0.405 | Dual specificity phosphatase 3 inhibitor | 0.405 0.013 CID_980 | CID_980 | |
| 0.338 | 0.038 | 0.38 | Pyruvate kinase inhibitor | 0.38 0.025 CID_980 | CID_980 | |
| 0.398 | 0.102 | 0.398 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.394 0.106 CID_980 | ||
| 0.3 | 0.006 | 0.464 | Histidine decarboxylase inhibitor | 0.464 0.003 CID_980 | CID_980 | |
| 0.332 | 0.039 | 0.346 | Transcription factor STAT3 inhibitor | 0.346 0.034 CID_980 | CID_980 | |
| 0.317 | 0.026 | 0.449 | Tyrosine 3 hydroxylase inhibitor | 0.449 0.005 CID_980 | CID_980 | |
| 0.32 | 0.034 | 0.32 | Cyclic AMP phosphodiesterase inhibitor | 0.32 0.034 CID_980 | ||
| 0.304 | 0.019 | 0.304 | Cytidine deaminase inhibitor | 0.257 0.027 CID_980 | ||
| 0.309 | 0.023 | 0.311 | DNA methyltransferase I inhibitor | 0.311 0.022 CID_980 | CID_980 | |
| 0.363 | 0.078 | 0.38 | Prostaglandin dehydrogenase inhibitor | 0.38 0.073 CID_980 | CID_980 | |
| 0.305 | 0.022 | 0.456 | Mcl-1 antagonist | 0.456 0.007 CID_980 | CID_980 | |
| 0.286 | 0.005 | 0.882 | Alcohol oxidase inhibitor | 0.882 0.002 CID_980 | CID_980 | |
| 0.285 | 0.005 | 0.46 | Triose-phosphate isomerase inhibitor | 0.46 0.003 CID_980 | CID_980 | |
| 0.292 | 0.015 | 0.292 | Histone acetyltransferase inhibitor | 0.28 0.018 CID_980 | ||
| 0.271 | 0.005 | 0.301 | CF transmembrane conductance regulator agonist | 0.301 0.004 CID_980 | CID_980 | |
| 0.314 | 0.048 | 0.359 | Transcription factor STAT inhibitor | 0.359 0.031 CID_980 | CID_980 | |
| 0.278 | 0.015 | 0.295 | Alkaline phosphatase inhibitor | 0.295 0.012 CID_980 | CID_980 | |
| 0.309 | 0.05 | 0.512 | Free radical scavenger | 0.512 0.015 CID_980 | CID_980 | |
| 0.301 | 0.044 | 0.328 | 5 Hydroxytryptamine uptake stimulant | 0.328 0.033 CID_980 | CID_980 | |
| 0.284 | 0.033 | 0.285 | DNA methylase inhibitor | 0.285 0.032 CID_980 | CID_980 | |
| 0.274 | 0.024 | 0.274 | Tumour necrosis factor antagonist | 0.163 0.085 CID_980 | ||
| 0.251 | 0.009 | 0.39 | Carbonic anhydrase III inhibitor | 0.39 0.004 CID_980 | CID_980 | |
| 0.273 | 0.033 | 0.388 | Dual specificity phosphatase inhibitor | 0.388 0.016 CID_980 | CID_980 | |
| 0.262 | 0.023 | 0.347 | Heat shock protein 90 alpha antagonist | 0.347 0.009 CID_980 | CID_980 | |
| 0.322 | 0.084 | 0.322 | Thyroid hormone antagonist | 0.28 0.104 CID_980 | ||
| 0.3 | 0.065 | 0.317 | Hypoxia-inducible factor 1 alpha inhibitor | 0.317 0.058 CID_980 | CID_980 | |
| 0.253 | 0.022 | 0.318 | Interleukin 6 antagonist | 0.318 0.013 CID_980 | CID_980 | |
| 0.311 | 0.084 | 0.373 | Cholesterol antagonist | 0.373 0.056 CID_980 | CID_980 | |
| 0.246 | 0.019 | 0.374 | Aldehyde dehydrogenase inhibitor | 0.374 0.006 CID_980 | CID_980 | |
| 0.261 | 0.038 | 0.261 | Non-steroidal antiinflammatory agent | 0.247 0.044 CID_980 | ||
| 0.306 | 0.085 | 0.306 | Thyroid hormone beta antagonist | 0.258 0.114 CID_980 | ||
| 0.28 | 0.059 | 0.323 | Interleukin agonist | 0.323 0.038 CID_980 | CID_980 | |
| 0.228 | 0.01 | 0.326 | Potassium channel (Ca-activated) activator | 0.326 0.005 CID_980 | CID_980 | |
| 0.261 | 0.044 | 0.346 | RNA-directed DNA polymerase inhibitor | 0.346 0.024 CID_980 | CID_980 | |
| 0.231 | 0.016 | 0.427 | Interleukin 4 antagonist | 0.427 0.005 CID_980 | CID_980 | |
| 0.226 | 0.012 | 0.327 | Adenylate kinase inhibitor | 0.327 0.005 CID_980 | CID_980 | |
| 0.23 | 0.016 | 0.23 | Cathepsin H inhibitor | 0.228 0.016 CID_980 | ||
| 0.265 | 0.052 | 0.265 | Calpain inhibitor | 0.263 0.053 CID_980 | ||
| 0.298 | 0.095 | 0.376 | Transcription factor NF kappa B inhibitor | 0.376 0.069 CID_980 | CID_980 | |
| 0.238 | 0.038 | 0.269 | Amyloid beta precursor protein antagonist | 0.269 0.026 CID_980 | CID_980 | |
| 0.207 | 0.008 | 0.236 | Thioredoxin inhibitor | 0.236 0.005 CID_980 | CID_980 | |
| 0.209 | 0.01 | 0.257 | HIV-1 integrase (Overall Integration) inhibitor | 0.257 0.005 CID_980 | CID_980 | |
| 0.32 | 0.121 | 0.434 | Antibacterial | 0.434 0.063 CID_980 | CID_980 | |
| 0.224 | 0.026 | 0.261 | Neurotensin receptor agonist | 0.261 0.019 CID_980 | CID_980 | |
| 0.201 | 0.004 | 0.206 | Thioredoxin reductase inhibitor | 0.206 0.004 CID_980 | CID_980 | |
| 0.205 | 0.01 | 0.252 | Urease inhibitor | 0.252 0.006 CID_980 | CID_980 | |
| 0.218 | 0.024 | 0.218 | Calcium channel blocker | 0.134 0.073 CID_980 | ||
| 0.214 | 0.023 | 0.248 | Alkylator | 0.248 0.017 CID_980 | CID_980 | |
| 0.219 | 0.028 | 0.219 | Acetylcholinesterase inhibitor | 0.134 0.066 CID_980 | ||
| 0.197 | 0.007 | 0.307 | DOPA decarboxylase inhibitor | 0.307 0.003 CID_980 | CID_980 | |
| 0.215 | 0.026 | 0.215 | Toll-Like receptor antagonist | 0.201 0.03 CID_980 | ||
| 0.198 | 0.009 | 0.198 | Sphingosine 1-phosphate receptor 4 antagonist | 0.195 0.01 CID_980 | ||
| 0.199 | 0.014 | 0.238 | Carbonic anhydrase XIII inhibitor | 0.238 0.01 CID_980 | CID_980 | |
| 0.193 | 0.012 | 0.223 | TRPA1 agonist | 0.223 0.007 CID_980 | CID_980 | |
| 0.213 | 0.032 | 0.282 | Heat shock protein 90 antagonist | 0.282 0.013 CID_980 | CID_980 | |
| 0.213 | 0.036 | 0.277 | Melanin inhibitor | 0.277 0.025 CID_980 | CID_980 | |
| 0.19 | 0.013 | 0.19 | Multidrug resistance-associated protein 1 inhibitor | 0.16 0.021 CID_980 | ||
| 0.183 | 0.007 | 0.212 | Glutathione S-transferase inhibitor | 0.212 0.005 CID_980 | CID_980 | |
| 0.179 | 0.004 | 0.256 | D-Ala-D-Ala ligase inhibitor | 0.256 0.003 CID_980 | CID_980 | |
| 0.177 | 0.002 | 0.177 | Ryanodine receptor antagonist | 0.127 0.003 CID_980 | ||
| 0.245 | 0.07 | 0.323 | DNA synthesis inhibitor | 0.323 0.036 CID_980 | CID_980 | |
| 0.236 | 0.062 | 0.36 | Amyloid beta aggregation inhibitor | 0.36 0.032 CID_980 | CID_980 | |
| 0.182 | 0.012 | 0.26 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.26 0.005 CID_980 | CID_980 | |
| 0.185 | 0.014 | 0.566 | Porphobilinogen synthase inhibitor | 0.566 0.003 CID_980 | CID_980 | |
| 0.303 | 0.133 | 0.303 | Beta lactamase inhibitor | |||
| 0.18 | 0.013 | 0.18 | Phosphodiesterase 7B inhibitor | 0.125 0.034 CID_980 | ||
| 0.181 | 0.015 | 0.283 | Beta glucuronidase inhibitor | 0.283 0.007 CID_980 | CID_980 | |
| 0.211 | 0.046 | 0.211 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.061 CID_980 | ||
| 0.195 | 0.031 | 0.215 | GABA C receptor rho-2 antagonist | 0.215 0.022 CID_980 | CID_980 | |
| 0.167 | 0.004 | 0.235 | GABA B receptor agonist | 0.235 0.003 CID_980 | CID_980 | |
| 0.173 | 0.01 | 0.173 | Beta tubulin antagonist | 0.114 0.019 CID_980 | ||
| 0.178 | 0.015 | 0.443 | Creatine kinase inhibitor | 0.443 0.003 CID_980 | CID_980 | |
| 0.217 | 0.054 | 0.217 | P-glycoprotein inhibitor | 0.153 0.113 CID_980 | ||
| 0.173 | 0.011 | 0.186 | Toll-Like receptor 4 antagonist | 0.186 0.008 CID_980 | CID_980 | |
| 0.197 | 0.037 | 0.244 | Hexokinase inhibitor | 0.244 0.018 CID_980 | CID_980 | |
| 0.229 | 0.069 | 0.229 | Antimitotic | |||
| 0.166 | 0.008 | 0.166 | Calcium channel L-type blocker | 0.103 0.023 CID_980 | ||
| 0.193 | 0.036 | 0.193 | Interleukin 1 antagonist | 0.14 0.066 CID_980 | ||
| 0.318 | 0.162 | 0.318 | MAP kinase 1 inhibitor | |||
| 0.172 | 0.017 | 0.172 | DNA repair enzyme inhibitor | 0.17 0.018 CID_980 | ||
| 0.182 | 0.028 | 0.182 | Alpha 2b adrenoreceptor antagonist | 0.135 0.047 CID_980 | ||
| 0.213 | 0.06 | 0.213 | I kappa B kinase epsilon inhibitor | 0.179 0.09 CID_980 | ||
| 0.182 | 0.029 | 0.276 | Cystathionine beta-synthase inhibitor | 0.276 0.012 CID_980 | CID_980 | |
| 0.178 | 0.025 | 0.178 | Interleukin 1b antagonist | |||
| 0.177 | 0.025 | 0.262 | Xanthine oxidase inhibitor | 0.262 0.011 CID_980 | CID_980 | |
| 0.157 | 0.009 | 0.157 | Alpha tubulin antagonist | 0.128 0.012 CID_980 | ||
| 0.176 | 0.028 | 0.192 | Sphingosine 1-phosphate receptor 5 antagonist | 0.192 0.015 CID_980 | CID_980 | |
| 0.177 | 0.029 | 0.177 | Antibacterial (Helicobacter pylori) | 0.171 0.032 CID_980 | ||
| 0.167 | 0.02 | 0.182 | Heat shock protein 70 antagonist | 0.182 0.011 CID_980 | CID_980 | |
| 0.172 | 0.032 | 0.172 | Cyclooxygenase 3 inhibitor | 0.171 0.033 CID_980 | ||
| 0.186 | 0.047 | 0.206 | Arachidonic acid antagonist | 0.206 0.028 CID_980 | CID_980 | |
| 0.185 | 0.047 | 0.239 | Interferon gamma antagonist | 0.239 0.03 CID_980 | CID_980 | |
| 0.235 | 0.098 | 0.238 | Gastrin inhibitor | 0.238 0.094 CID_980 | CID_980 | |
| 0.158 | 0.02 | 0.158 | Phosphodiesterase IV inhibitor | |||
| 0.183 | 0.047 | 0.183 | MAO inhibitor | 0.183 0.046 CID_980 | ||
| 0.151 | 0.016 | 0.151 | Acetylcholine release stimulant | 0.113 0.06 CID_980 | ||
| 0.141 | 0.007 | 0.141 | Granulocyte macrophage colony stimulating factor agonist | 0.114 0.02 CID_980 | ||
| 0.152 | 0.019 | 0.152 | Phosphodiesterase 4D inhibitor | |||
| 0.137 | 0.004 | 0.137 | Calcium channel P-type blocker | 0.078 0.017 CID_980 | ||
| 0.135 | 0.003 | 0.135 | Transcription factor RelA inhibitor | 0.121 0.004 CID_980 | ||
| 0.159 | 0.029 | 0.223 | Interleukin 8 antagonist | 0.223 0.008 CID_980 | CID_980 | |
| 0.141 | 0.012 | 0.262 | Potassium channel large-conductance Ca-activated activator | 0.262 0.005 CID_980 | CID_980 | |
| 0.172 | 0.044 | 0.335 | Alpha-N-acetylglucosaminidase inhibitor | 0.335 0.013 CID_980 | CID_980 | |
| 0.217 | 0.089 | 0.227 | Antiamyloidogenic | 0.227 0.083 CID_980 | CID_980 | |
| 0.133 | 0.005 | 0.133 | Potassium channel intermediate-conductance Ca-activated blocker | 0.08 0.017 CID_980 | ||
| 0.141 | 0.013 | 0.18 | Interleukin 5 antagonist | 0.18 0.007 CID_980 | CID_980 | |
| 0.182 | 0.055 | 0.194 | ATPase inhibitor | 0.194 0.042 CID_980 | CID_980 | |
| 0.167 | 0.041 | 0.274 | Monophenol monooxygenase inhibitor | 0.274 0.021 CID_980 | CID_980 | |
| 0.142 | 0.016 | 0.179 | Carbonic anhydrase V inhibitor | 0.179 0.009 CID_980 | CID_980 | |
| 0.137 | 0.011 | 0.158 | Sphingosine 1-phosphate receptor 4 agonist | 0.158 0.007 CID_980 | CID_980 | |
| 0.154 | 0.029 | 0.168 | Photosensitizer | 0.168 0.022 CID_980 | CID_980 | |
| 0.182 | 0.058 | 0.304 | Phospholipase C inhibitor | 0.304 0.018 CID_980 | CID_980 | |
| 0.171 | 0.048 | 0.171 | Cytokine production inhibitor | 0.119 0.09 CID_980 | ||
| 0.174 | 0.053 | 0.213 | Protein kinase stimulant | 0.213 0.037 CID_980 | CID_980 | |
| 0.144 | 0.024 | 0.219 | Androgen antagonist | 0.219 0.012 CID_980 | CID_980 | |
| 0.165 | 0.045 | 0.165 | Neuropeptide Y1 antagonist | 0.164 0.046 CID_980 | ||
| 0.194 | 0.074 | 0.194 | Focal adhesion kinase 2 inhibitor | |||
| 0.125 | 0.004 | 0.207 | Catechol O-methyltransferase inhibitor | 0.207 0.003 CID_980 | CID_980 | |
| 0.22 | 0.101 | 0.436 | Antioxidant | 0.436 0.029 CID_980 | CID_980 | |
| 0.154 | 0.036 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | 0.169 0.022 CID_980 | CID_980 | |
| 0.13 | 0.012 | 0.235 | Biliverdin reductase inhibitor | 0.235 0.004 CID_980 | CID_980 | |
| 0.168 | 0.049 | 0.243 | Cell wall synthesis inhibitor | 0.243 0.017 CID_980 | CID_980 | |
| 0.133 | 0.015 | 0.161 | Carbonic anhydrase VA inhibitor | 0.161 0.009 CID_980 | CID_980 | |
| 0.145 | 0.027 | 0.145 | Sphingomyelinase inhibitor | 0.1 0.059 CID_980 | ||
| 0.158 | 0.04 | 0.169 | Pregnane X receptor agonist | 0.169 0.027 CID_980 | CID_980 | |
| 0.156 | 0.04 | 0.189 | DNA intercalator | 0.189 0.029 CID_980 | CID_980 | |
| 0.136 | 0.02 | 0.189 | Macrophage migration inhibitory factor inhibitor | 0.189 0.009 CID_980 | CID_980 | |
| 0.126 | 0.01 | 0.174 | Purinergic P2X1 antagonist | 0.174 0.005 CID_980 | CID_980 | |
| 0.141 | 0.026 | 0.141 | Electron transport complex I inhibitor | |||
| 0.154 | 0.04 | 0.17 | MAO A inhibitor | 0.17 0.036 CID_980 | CID_980 | |
| 0.159 | 0.045 | 0.159 | Anesthetic local | 0.144 0.052 CID_980 | ||
| 0.152 | 0.038 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.169 0.014 CID_980 | CID_980 | |
| 0.151 | 0.037 | 0.226 | Aminopeptidase B inhibitor | 0.226 0.016 CID_980 | CID_980 | |
| 0.147 | 0.034 | 0.147 | Alpha 2c adrenoreceptor antagonist | 0.113 0.055 CID_980 | ||
| 0.116 | 0.004 | 0.131 | Dihydropteroate synthase inhibitor | 0.131 0.004 CID_980 | CID_980 | |
| 0.228 | 0.116 | 0.282 | Lipoxygenase inhibitor | 0.282 0.08 CID_980 | CID_980 | |
| 0.202 | 0.091 | 0.307 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.307 0.048 CID_980 | CID_980 | |
| 0.173 | 0.062 | 0.225 | Catenin beta inhibitor | 0.225 0.018 CID_980 | CID_980 | |
| 0.134 | 0.025 | 0.232 | Carbonic anhydrase VI inhibitor | 0.232 0.01 CID_980 | CID_980 | |
| 0.132 | 0.023 | 0.187 | NADH dehydrogenase inhibitor | 0.187 0.012 CID_980 | CID_980 | |
| 0.131 | 0.022 | 0.232 | Phosphofructokinase-1 inhibitor | 0.232 0.009 CID_980 | CID_980 | |
| 0.125 | 0.017 | 0.158 | Aromatase inhibitor | 0.158 0.012 CID_980 | CID_980 | |
| 0.145 | 0.039 | 0.145 | MAO B inhibitor | 0.145 0.039 CID_980 | ||
| 0.115 | 0.008 | 0.127 | Glutamate (mGluR group III) agonist | 0.127 0.006 CID_980 | CID_980 | |
| 0.141 | 0.035 | 0.151 | Caspase 3 inhibitor | 0.151 0.027 CID_980 | CID_980 | |
| 0.142 | 0.037 | 0.311 | GABA C receptor agonist | 0.311 0.009 CID_980 | CID_980 | |
| 0.132 | 0.028 | 0.318 | Alcohol dehydrogenase inhibitor | 0.318 0.005 CID_980 | CID_980 | |
| 0.118 | 0.017 | 0.19 | GABA aminotransferase inhibitor | 0.19 0.005 CID_980 | CID_980 | |
| 0.137 | 0.036 | 0.137 | Bronchodilator | 0.127 0.04 CID_980 | ||
| 0.11 | 0.009 | 0.145 | Plasminogen activator inhibitor antagonist | 0.145 0.005 CID_980 | CID_980 | |
| 0.113 | 0.013 | 0.184 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.184 0.004 CID_980 | CID_980 | |
| 0.136 | 0.036 | 0.169 | Carbonic anhydrase XV inhibitor | 0.169 0.025 CID_980 | CID_980 | |
| 0.112 | 0.012 | 0.288 | NMDA 2C receptor antagonist | 0.288 0.004 CID_980 | CID_980 | |
| 0.107 | 0.007 | 0.107 | Glutamate (mGluR7) antagonist | 0.089 0.018 CID_980 | ||
| 0.153 | 0.054 | 0.18 | M17 leucyl aminopeptidase inhibitor | 0.18 0.04 CID_980 | CID_980 | |
| 0.125 | 0.026 | 0.152 | Lanosterol 14 alpha demethylase inhibitor | 0.152 0.011 CID_980 | CID_980 | |
| 0.12 | 0.022 | 0.12 | Glutamate release inhibitor | 0.098 0.047 CID_980 | ||
| 0.11 | 0.012 | 0.131 | NMDA receptor glycine site agonist | 0.131 0.006 CID_980 | CID_980 | |
| 0.143 | 0.046 | 0.145 | Vanilloid 1 agonist | 0.145 0.044 CID_980 | CID_980 | |
| 0.103 | 0.008 | 0.103 | Exportin-1 inhibitor | 0.085 0.02 CID_980 | ||
| 0.205 | 0.11 | 0.238 | Neuropeptide Y2 antagonist | 0.238 0.068 CID_980 | CID_980 | |
| 0.108 | 0.014 | 0.138 | Bcl2 antagonist | 0.138 0.007 CID_980 | CID_980 | |
| 0.141 | 0.047 | 0.141 | Beta amyloid protein antagonist | 0.098 0.092 CID_980 | ||
| 0.132 | 0.041 | 0.174 | Transcription factor STAT6 inhibitor | 0.174 0.012 CID_980 | CID_980 | |
| 0.195 | 0.106 | 0.31 | Peptidyltransferase inhibitor | 0.31 0.021 CID_980 | CID_980 | |
| 0.101 | 0.013 | 0.103 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.103 0.012 CID_980 | CID_980 | |
| 0.12 | 0.032 | 0.167 | Potassium channel activator | 0.167 0.015 CID_980 | CID_980 | |
| 0.132 | 0.045 | 0.132 | Calcium channel (voltage-sensitive) blocker | |||
| 0.09 | 0.003 | 0.113 | Glutamate (mGluR8) agonist | 0.113 0.003 CID_980 | CID_980 | |
| 0.102 | 0.015 | 0.102 | Glutamate (mGluR1) antagonist | 0.086 0.021 CID_980 | ||
| 0.092 | 0.006 | 0.092 | Sodium/calcium exchanger inhibitor | 0.071 0.012 CID_980 | ||
| 0.113 | 0.027 | 0.128 | Bile acid receptor antagonist | 0.128 0.014 CID_980 | CID_980 | |
| 0.099 | 0.015 | 0.155 | Androgen agonist | 0.155 0.007 CID_980 | CID_980 | |
| 0.092 | 0.01 | 0.19 | CD45 antagonist | 0.19 0.005 CID_980 | CID_980 | |
| 0.094 | 0.012 | 0.094 | Nitric oxide donor | 0.093 0.013 CID_980 | ||
| 0.088 | 0.006 | 0.095 | Glutamate (mGluR group III) antagonist | 0.095 0.005 CID_980 | CID_980 | |
| 0.086 | 0.005 | 0.086 | Fructose-1,6-bisphosphatase inhibitor | 0.085 0.006 CID_980 | ||
| 0.106 | 0.026 | 0.25 | Glutamate decarboxylase inhibitor | 0.25 0.004 CID_980 | CID_980 | |
| 0.102 | 0.023 | 0.127 | Estrogen-related receptor beta agonist | 0.127 0.007 CID_980 | CID_980 | |
| 0.083 | 0.004 | 0.122 | NMDA 2D receptor antagonist | 0.122 0.004 CID_980 | CID_980 | |
| 0.092 | 0.013 | 0.109 | Carbonic anhydrase XIV inhibitor | 0.109 0.009 CID_980 | CID_980 | |
| 0.115 | 0.036 | 0.115 | Glutamate (mGluR7) agonist | |||
| 0.092 | 0.013 | 0.146 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.146 0.005 CID_980 | CID_980 | |
| 0.152 | 0.075 | 0.152 | Cholinergic | |||
| 0.146 | 0.069 | 0.168 | Glycogen synthase kinase-3 alpha inhibitor | 0.168 0.054 CID_980 | CID_980 | |
| 0.138 | 0.062 | 0.138 | Death-associated protein kinase 1 inhibitor | |||
| 0.147 | 0.072 | 0.163 | Thiol protease inhibitor | 0.163 0.059 CID_980 | CID_980 | |
| 0.183 | 0.109 | 0.27 | Dyrk kinase inhibitor | 0.27 0.063 CID_980 | CID_980 | |
| 0.117 | 0.043 | 0.154 | Anabolic | 0.154 0.016 CID_980 | CID_980 | |
| 0.082 | 0.009 | 0.082 | Lysophosphatidic acid 3 receptor antagonist | 0.075 0.012 CID_980 | ||
| 0.088 | 0.015 | 0.135 | Glycine transporter 2 inhibitor | 0.135 0.009 CID_980 | CID_980 | |
| 0.08 | 0.008 | 0.08 | Potassium channel (Inward rectifier) activator | 0.079 0.008 CID_980 | ||
| 0.124 | 0.052 | 0.16 | 5 Hydroxytryptamine 3A agonist | 0.16 0.03 CID_980 | CID_980 | |
| 0.085 | 0.014 | 0.085 | Cyclin D1 inhibitor | 0.067 0.033 CID_980 | ||
| 0.085 | 0.014 | 0.092 | MDM2 inhibitor | 0.092 0.01 CID_980 | CID_980 | |
| 0.115 | 0.045 | 0.155 | GABA C receptor rho-1 antagonist | 0.155 0.019 CID_980 | CID_980 | |
| 0.076 | 0.008 | 0.076 | Potassium channel (ATP-sensitive) activator | 0.075 0.008 CID_980 | ||
| 0.124 | 0.056 | 0.124 | Microtubule formation inhibitor | 0.118 0.063 CID_980 | ||
| 0.089 | 0.022 | 0.181 | Argininosuccinate synthase inhibitor | 0.181 0.009 CID_980 | CID_980 | |
| 0.078 | 0.011 | 0.12 | Dihydroorotate oxidase inhibitor | 0.12 0.004 CID_980 | CID_980 | |
| 0.075 | 0.009 | 0.111 | Glutamate (mGluR4) antagonist | 0.111 0.005 CID_980 | CID_980 | |
| 0.099 | 0.033 | 0.099 | Phosphodiesterase 3A inhibitor | |||
| 0.079 | 0.013 | 0.079 | Nicotinic alpha3beta2 receptor antagonist | 0.077 0.014 CID_980 | ||
| 0.098 | 0.033 | 0.098 | Metalloproteinase-9 inhibitor | 0.091 0.037 CID_980 | ||
| 0.102 | 0.038 | 0.16 | Catalase inhibitor | 0.16 0.024 CID_980 | CID_980 | |
| 0.085 | 0.022 | 0.133 | Xanthine dehydrogenase inhibitor | 0.133 0.009 CID_980 | CID_980 | |
| 0.09 | 0.027 | 0.09 | Acetylcholine M5 receptor agonist | |||
| 0.095 | 0.033 | 0.187 | Glutamate dehydrogenase inhibitor | 0.187 0.011 CID_980 | CID_980 | |
| 0.091 | 0.029 | 0.091 | Phosphodiesterase 4B inhibitor | |||
| 0.118 | 0.057 | 0.122 | Mucolytic | 0.122 0.052 CID_980 | CID_980 | |
| 0.093 | 0.033 | 0.093 | T cell inhibitor | 0.089 0.039 CID_980 | ||
| 0.065 | 0.005 | 0.076 | Kainate receptor agonist | 0.076 0.004 CID_980 | CID_980 | |
| 0.074 | 0.014 | 0.093 | Alpha-mannosidase inhibitor | 0.093 0.008 CID_980 | CID_980 | |
| 0.096 | 0.037 | 0.109 | 3C-Like protease (SARS coronavirus) inhibitor | 0.109 0.025 CID_980 | CID_980 | |
| 0.14 | 0.081 | 0.179 | Adenylate cyclase stimulant | 0.179 0.026 CID_980 | CID_980 | |
| 0.085 | 0.026 | 0.142 | NMDA receptor agonist | 0.142 0.009 CID_980 | CID_980 | |
| 0.063 | 0.005 | 0.063 | Kynurenine 3 monooxygenase inhibitor | 0.05 0.006 CID_980 | ||
| 0.083 | 0.025 | 0.083 | Potassium channel (ATP-sensitive) blocker | 0.069 0.043 CID_980 | ||
| 0.156 | 0.099 | 0.189 | Platelet adhesion inhibitor | 0.189 0.077 CID_980 | CID_980 | |
| 0.167 | 0.111 | 0.18 | Insulin sensitizer | 0.18 0.095 CID_980 | CID_980 | |
| 0.096 | 0.039 | 0.096 | Histamine H2 receptor antagonist | 0.08 0.065 CID_980 | ||
| 0.071 | 0.015 | 0.261 | NMDA receptor subunit 3B antagonist | 0.261 0.004 CID_980 | CID_980 | |
| 0.168 | 0.112 | 0.245 | Neurotrophic factor enhancer | 0.245 0.041 CID_980 | CID_980 | |
| 0.096 | 0.041 | 0.096 | Inducible nitric-oxide synthase inhibitor | 0.091 0.047 CID_980 | ||
| 0.063 | 0.008 | 0.083 | Glutamate (mGluR4) agonist | 0.083 0.005 CID_980 | CID_980 | |
| 0.072 | 0.018 | 0.083 | Bcl-xL inhibitor | 0.083 0.01 CID_980 | CID_980 | |
| 0.076 | 0.022 | 0.076 | Phosphodiesterase 4A inhibitor | |||
| 0.079 | 0.026 | 0.121 | Carbonic anhydrase XII inhibitor | 0.121 0.016 CID_980 | CID_980 | |
| 0.08 | 0.027 | 0.103 | Carbonic anhydrase IX inhibitor | 0.103 0.019 CID_980 | CID_980 | |
| 0.108 | 0.054 | 0.108 | Factor V inhibitor | 0.108 0.054 CID_980 | ||
| 0.139 | 0.087 | 0.164 | Phospholipase A2 inhibitor | 0.164 0.063 CID_980 | CID_980 | |
| 0.062 | 0.009 | 0.062 | Dihydrofolate reductase inhibitor | 0.043 0.033 CID_980 | ||
| 0.111 | 0.06 | 0.21 | Ferrochelatase inhibitor | 0.21 0.02 CID_980 | CID_980 | |
| 0.06 | 0.009 | 0.06 | Potassium channel Kv1.1 blocker | 0.054 0.011 CID_980 | ||
| 0.084 | 0.033 | 0.119 | Carbonic anhydrase inhibitor | 0.119 0.022 CID_980 | CID_980 | |
| 0.065 | 0.014 | 0.088 | Mannosidase inhibitor | 0.088 0.007 CID_980 | CID_980 | |
| 0.134 | 0.083 | 0.134 | CDC-like kinase 1 inhibitor | |||
| 0.067 | 0.017 | 0.067 | Oleamide hydrolase inhibitor | 0.052 0.025 CID_980 | ||
| 0.124 | 0.074 | 0.167 | Toll-Like receptor 2 antagonist | 0.167 0.042 CID_980 | CID_980 | |
| 0.161 | 0.112 | 0.196 | MAP kinase kinase 2 inhibitor | 0.196 0.085 CID_980 | CID_980 | |
| 0.09 | 0.041 | 0.092 | CYP2A6 inhibitor | 0.092 0.04 CID_980 | CID_980 | |
| 0.057 | 0.008 | 0.057 | Heme oxygenase inhibitor | 0.057 0.007 CID_980 | ||
| 0.069 | 0.02 | 0.069 | 5 Hydroxytryptamine 7 agonist | 0.053 0.046 CID_980 | ||
| 0.09 | 0.042 | 0.117 | Glycine receptor antagonist | 0.117 0.02 CID_980 | CID_980 | |
| 0.08 | 0.032 | 0.082 | Neutrophil collagenase inhibitor | 0.082 0.031 CID_980 | CID_980 | |
| 0.093 | 0.045 | 0.104 | Myeloperoxidase inhibitor | 0.104 0.031 CID_980 | CID_980 | |
| 0.087 | 0.039 | 0.253 | NMDA 2 receptor antagonist | 0.253 0.006 CID_980 | CID_980 | |
| 0.077 | 0.03 | 0.096 | Beta adrenoreceptor antagonist | 0.096 0.018 CID_980 | CID_980 | |
| 0.087 | 0.04 | 0.132 | Keratolytic | 0.132 0.018 CID_980 | CID_980 | |
| 0.087 | 0.041 | 0.087 | Alpha 1b adrenoreceptor antagonist | |||
| 0.229 | 0.183 | 0.315 | 15-Lipoxygenase inhibitor | 0.315 0.121 CID_980 | CID_980 | |
| 0.102 | 0.056 | 0.102 | Nitric-oxide synthase inhibitor | 0.099 0.062 CID_980 | ||
| 0.053 | 0.007 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 CID_980 | CID_980 | |
| 0.088 | 0.043 | 0.088 | Alpha 2a adrenoreceptor antagonist | 0.071 0.056 CID_980 | ||
| 0.103 | 0.059 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.102 0.061 CID_980 | ||
| 0.056 | 0.012 | 0.065 | Nerve growth factor antagonist | 0.065 0.007 CID_980 | CID_980 | |
| 0.076 | 0.032 | 0.076 | Alpha 1d adrenoreceptor antagonist | |||
| 0.057 | 0.014 | 0.073 | GABA B receptor antagonist | 0.073 0.008 CID_980 | CID_980 | |
| 0.058 | 0.015 | 0.058 | Benzodiazepine antagonist | |||
| 0.056 | 0.013 | 0.056 | TRPM8 blocker | 0.044 0.02 CID_980 | ||
| 0.071 | 0.027 | 0.125 | Carbonic anhydrase VB inhibitor | 0.125 0.012 CID_980 | CID_980 | |
| 0.098 | 0.055 | 0.098 | Toll-Like receptor 3 antagonist | |||
| 0.114 | 0.071 | 0.138 | Cholesterol synthesis inhibitor | 0.138 0.051 CID_980 | CID_980 | |
| 0.052 | 0.01 | 0.053 | Integrin alpha2 antagonist | 0.053 0.01 CID_980 | CID_980 | |
| 0.129 | 0.086 | 0.129 | Activin receptor-like kinase 2 inhibitor | |||
| 0.128 | 0.086 | 0.214 | Farnesoid X receptor antagonist | 0.214 0.018 CID_980 | CID_980 | |
| 0.098 | 0.056 | 0.142 | Interleukin 12 antagonist | 0.142 0.015 CID_980 | CID_980 | |
| 0.053 | 0.012 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 CID_980 | CID_980 | |
| 0.069 | 0.028 | 0.069 | Phosphodiesterase 4C inhibitor | |||
| 0.068 | 0.027 | 0.096 | Botulinum neurotoxin type A inhibitor | 0.096 0.01 CID_980 | CID_980 | |
| 0.057 | 0.017 | 0.094 | Purinergic P2X4 antagonist | 0.094 0.005 CID_980 | CID_980 | |
| 0.063 | 0.022 | 0.063 | Potassium channel (Inward rectifier) blocker | 0.046 0.04 CID_980 | ||
| 0.044 | 0.004 | 0.065 | Estrogen-related receptor gamma antagonist | 0.065 0.002 CID_980 | CID_980 | |
| 0.061 | 0.021 | 0.061 | Phosphodiesterase 7A inhibitor | 0.054 0.032 CID_980 | ||
| 0.049 | 0.01 | 0.049 | Free fatty acid receptor 1 antagonist | 0.039 0.017 CID_980 | ||
| 0.067 | 0.029 | 0.078 | Beta 1 adrenoreceptor antagonist | 0.078 0.019 CID_980 | CID_980 | |
| 0.107 | 0.068 | 0.178 | GABA C receptor antagonist | 0.178 0.018 CID_980 | CID_980 | |
| 0.066 | 0.028 | 0.118 | Ornithine carbamoyltransferase inhibitor | 0.118 0.013 CID_980 | CID_980 | |
| 0.207 | 0.169 | 0.255 | Antithrombotic | 0.255 0.122 CID_980 | CID_980 | |
| 0.128 | 0.09 | 0.131 | Cyclooxygenase inhibitor | 0.131 0.087 CID_980 | CID_980 | |
| 0.052 | 0.015 | 0.083 | Kainate receptor 2 antagonist | 0.083 0.006 CID_980 | CID_980 | |
| 0.041 | 0.004 | 0.041 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.04 0.004 CID_980 | ||
| 0.062 | 0.026 | 0.062 | Pregnane X receptor antagonist | 0.061 0.028 CID_980 | ||
| 0.099 | 0.063 | 0.099 | Butyrylcholinesterase inhibitor | |||
| 0.044 | 0.008 | 0.044 | Adenosine uptake inhibitor | 0.038 0.016 CID_980 | ||
| 0.06 | 0.024 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_980 | CID_980 | |
| 0.085 | 0.05 | 0.085 | Caspase 7 inhibitor | |||
| 0.102 | 0.068 | 0.102 | Falcipain 3 inhibitor | |||
| 0.117 | 0.083 | 0.117 | Cyclooxygenase 2 inhibitor | 0.109 0.093 CID_980 | ||
| 0.053 | 0.019 | 0.081 | AICAR transformylase inhibitor | 0.081 0.007 CID_980 | CID_980 | |
| 0.055 | 0.022 | 0.06 | Collagenase inhibitor | 0.06 0.016 CID_980 | CID_980 | |
| 0.059 | 0.026 | 0.136 | AMPA receptor antagonist | 0.136 0.007 CID_980 | CID_980 | |
| 0.078 | 0.045 | 0.078 | Adenosine A3 receptor antagonist | 0.077 0.048 CID_980 | ||
| 0.069 | 0.036 | 0.069 | Phosphodiesterase VII inhibitor | |||
| 0.065 | 0.032 | 0.091 | Carbonic anhydrase II inhibitor | 0.091 0.021 CID_980 | CID_980 | |
| 0.082 | 0.05 | 0.086 | Metalloproteinase-2 inhibitor | 0.086 0.047 CID_980 | CID_980 | |
| 0.205 | 0.173 | 0.304 | Apoptosis antagonist | 0.304 0.083 CID_980 | CID_980 | |
| 0.095 | 0.064 | 0.095 | Platelet activating factor alpha antagonist | |||
| 0.063 | 0.033 | 0.086 | Carbonic anhydrase I inhibitor | 0.086 0.023 CID_980 | CID_980 | |
| 0.06 | 0.031 | 0.06 | Matrix metalloproteinase 1 inhibitor | 0.052 0.038 CID_980 | ||
| 0.05 | 0.021 | 0.113 | Kainate receptor antagonist | 0.113 0.006 CID_980 | CID_980 | |
| 0.074 | 0.045 | 0.074 | Benzodiazepine agonist | |||
| 0.053 | 0.024 | 0.074 | Carbonic anhydrase VII inhibitor | 0.074 0.014 CID_980 | CID_980 | |
| 0.054 | 0.025 | 0.077 | Glucose-6-phosphate isomerase inhibitor | 0.077 0.01 CID_980 | CID_980 | |
| 0.034 | 0.005 | 0.034 | Complement factor 1s inhibitor | 0.032 0.005 CID_980 | ||
| 0.094 | 0.065 | 0.113 | MAP kinase kinase 1 inhibitor | 0.113 0.041 CID_980 | CID_980 | |
| 0.086 | 0.058 | 0.264 | NMDA receptor antagonist | 0.264 0.008 CID_980 | CID_980 | |
| 0.057 | 0.028 | 0.057 | Glucose-6-phosphate translocase inhibitor | 0.052 0.034 CID_980 | ||
| 0.041 | 0.013 | 0.041 | Melatonin receptor 1A agonist | |||
| 0.032 | 0.007 | 0.032 | Acid ceramidase inhibitor | 0.028 0.012 CID_980 | ||
| 0.044 | 0.019 | 0.044 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.043 | 0.017 | 0.051 | Phosphoglycerate kinase inhibitor | 0.051 0.014 CID_980 | CID_980 | |
| 0.051 | 0.026 | 0.08 | Thymidylate synthase inhibitor | 0.08 0.007 CID_980 | CID_980 | |
| 0.048 | 0.023 | 0.048 | Guanylate cyclase inhibitor | 0.047 0.025 CID_980 | ||
| 0.101 | 0.076 | 0.132 | Protein kinase C gamma inhibitor | 0.132 0.043 CID_980 | CID_980 | |
| 0.031 | 0.006 | 0.031 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.059 | 0.035 | 0.127 | Maillard reaction inhibitor | 0.127 0.009 CID_980 | CID_980 | |
| 0.13 | 0.106 | 0.13 | MAP kinase 3 inhibitor | 0.125 0.119 CID_980 | ||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.044 | 0.021 | 0.049 | Progesterone antagonist | 0.049 0.018 CID_980 | CID_980 | |
| 0.044 | 0.021 | 0.056 | Alpha 1d adrenoreceptor agonist | 0.056 0.013 CID_980 | CID_980 | |
| 0.055 | 0.033 | 0.164 | NMDA 2A receptor antagonist | 0.164 0.006 CID_980 | CID_980 | |
| 0.084 | 0.062 | 0.124 | Histamine N-methyltransferase inhibitor | 0.124 0.027 CID_980 | CID_980 | |
| 0.055 | 0.033 | 0.055 | Heparanase inhibitor | 0.052 0.039 CID_980 | ||
| 0.111 | 0.089 | 0.148 | Cyclooxygenase 1 inhibitor | 0.148 0.058 CID_980 | CID_980 | |
| 0.044 | 0.022 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.009 CID_980 | CID_980 | |
| 0.088 | 0.066 | 0.088 | Polo-like kinase-1 inhibitor | |||
| 0.044 | 0.023 | 0.181 | NMDA receptor subunit 3A antagonist | 0.181 0.004 CID_980 | CID_980 | |
| 0.054 | 0.033 | 0.079 | Aconitate hydratase inhibitor | 0.079 0.014 CID_980 | CID_980 | |
| 0.072 | 0.051 | 0.086 | Glycine receptor agonist | 0.086 0.032 CID_980 | CID_980 | |
| 0.075 | 0.055 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.102 0.03 CID_980 | CID_980 | |
| 0.024 | 0.003 | 0.024 | Progesterone receptor A antagonist | 0.017 0.004 CID_980 | ||
| 0.05 | 0.03 | 0.05 | Potassium channel Kv1.3 blocker | |||
| 0.095 | 0.075 | 0.098 | Expectorant | 0.098 0.071 CID_980 | CID_980 | |
| 0.035 | 0.015 | 0.035 | Epoxide hydrolase 1 inhibitor | |||
| 0.036 | 0.016 | 0.039 | Methionyl aminopeptidase 1 inhibitor | 0.039 0.013 CID_980 | CID_980 | |
| 0.038 | 0.018 | 0.038 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.066 | 0.047 | 0.066 | Phosphodiesterase III inhibitor | |||
| 0.142 | 0.123 | 0.152 | Psychostimulant | 0.152 0.114 CID_980 | CID_980 | |
| 0.023 | 0.004 | 0.032 | Thromboxane A2 agonist | 0.032 0.003 CID_980 | CID_980 | |
| 0.027 | 0.009 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.013 CID_980 | ||
| 0.038 | 0.02 | 0.058 | Fumarate hydratase inhibitor | 0.058 0.011 CID_980 | CID_980 | |
| 0.06 | 0.043 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.109 0.018 CID_980 | CID_980 | |
| 0.037 | 0.019 | 0.037 | Carnitine palmitoyltransferase inhibitor | |||
| 0.025 | 0.008 | 0.025 | Factor XIII inhibitor | 0.023 0.01 CID_980 | ||
| 0.024 | 0.008 | 0.026 | Progesterone receptor B antagonist | 0.026 0.007 CID_980 | CID_980 | |
| 0.095 | 0.078 | 0.133 | AMP-activated protein kinase stimulant | 0.133 0.039 CID_980 | CID_980 | |
| 0.074 | 0.057 | 0.074 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.081 | 0.065 | 0.081 | Alpha 2 adrenoreceptor antagonist | |||
| 0.02 | 0.004 | 0.038 | Glutamate (mGluR6) agonist | 0.038 0.003 CID_980 | CID_980 | |
| 0.189 | 0.174 | 0.263 | Insulysin inhibitor | 0.263 0.085 CID_980 | CID_980 | |
| 0.11 | 0.095 | 0.11 | Nav1.2 sodium channel blocker | |||
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | 0.026 0.025 CID_980 | ||
| 0.079 | 0.065 | 0.086 | Bcr-Abl kinase inhibitor | 0.086 0.056 CID_980 | CID_980 | |
| 0.035 | 0.021 | 0.048 | Estrogen-related receptor alpha antagonist | 0.048 0.014 CID_980 | CID_980 | |
| 0.028 | 0.014 | 0.066 | NMDA receptor glycine site antagonist | 0.066 0.005 CID_980 | CID_980 | |
| 0.025 | 0.011 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 CID_980 | CID_980 | |
| 0.04 | 0.026 | 0.052 | GABA uptake inhibitor | 0.052 0.014 CID_980 | CID_980 | |
| 0.028 | 0.015 | 0.033 | Integrin alpha2beta1 antagonist | 0.033 0.01 CID_980 | CID_980 | |
| 0.039 | 0.025 | 0.039 | DNA gyrase subunit B inhibitor | |||
| 0.028 | 0.014 | 0.028 | Complement factor 1r inhibitor | |||
| 0.062 | 0.049 | 0.062 | Aryl hydrocarbon receptor antagonist | |||
| 0.051 | 0.039 | 0.051 | Alpha 1L adrenoreceptor antagonist | |||
| 0.017 | 0.005 | 0.017 | Human herpes virus 5 capsid protein P40 inhibitor | 0.013 0.008 CID_980 | ||
| 0.038 | 0.026 | 0.038 | Diamine oxidase inhibitor | |||
| 0.075 | 0.063 | 0.075 | Platelet growth factor antagonist | |||
| 0.029 | 0.018 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CID_980 | CID_980 | |
| 0.027 | 0.016 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.012 CID_980 | CID_980 | |
| 0.074 | 0.063 | 0.085 | Interferon agonist | 0.085 0.045 CID_980 | CID_980 | |
| 0.085 | 0.074 | 0.147 | Prolactin inhibitor | 0.147 0.023 CID_980 | CID_980 | |
| 0.062 | 0.052 | 0.062 | Matrix metalloproteinase inhibitor | |||
| 0.122 | 0.111 | 0.327 | NOS3 expression enhancer | 0.327 0.014 CID_980 | CID_980 | |
| 0.053 | 0.043 | 0.087 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.087 0.018 CID_980 | CID_980 | |
| 0.054 | 0.044 | 0.112 | Fatty acid synthase inhibitor | 0.112 0.008 CID_980 | CID_980 | |
| 0.043 | 0.034 | 0.043 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.047 | 0.038 | 0.054 | Bombesin 2 receptor antagonist | 0.054 0.029 CID_980 | CID_980 | |
| 0.061 | 0.053 | 0.074 | Beta 3 adrenoreceptor antagonist | 0.074 0.029 CID_980 | CID_980 | |
| 0.015 | 0.007 | 0.015 | Carbonic anhydrase XI inhibitor | 0.013 0.008 CID_980 | ||
| 0.049 | 0.042 | 0.05 | GABA A receptor antagonist | 0.05 0.041 CID_980 | CID_980 | |
| 0.019 | 0.012 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.111 | 0.104 | 0.265 | Lipid peroxidase inhibitor | 0.265 0.024 CID_980 | CID_980 | |
| 0.03 | 0.024 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.129 | 0.123 | 0.14 | LIM domain kinase 1 inhibitor | 0.14 0.109 CID_980 | CID_980 | |
| 0.02 | 0.014 | 0.02 | Imidazoline I1 receptor antagonist | |||
| 0.05 | 0.045 | 0.053 | GABA receptor antagonist | 0.053 0.04 CID_980 | CID_980 | |
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.078 | 0.073 | 0.078 | mTOR complex 2 inhibitor | 0.077 0.076 CID_980 | ||
| 0.065 | 0.06 | 0.079 | Cathepsin G inhibitor | 0.079 0.045 CID_980 | CID_980 | |
| 0.059 | 0.055 | 0.072 | Interferon inducer | 0.072 0.033 CID_980 | CID_980 | |
| 0.056 | 0.051 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.024 | 0.02 | 0.024 | Sigma 2 receptor antagonist | |||
| 0.062 | 0.059 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.035 CID_980 | CID_980 | |
| 0.035 | 0.032 | 0.05 | Cathepsin L2 inhibitor | 0.05 0.022 CID_980 | CID_980 | |
| 0.026 | 0.023 | 0.026 | Cyclin E2 inhibitor | |||
| 0.096 | 0.093 | 0.106 | Proteasome inhibitor | 0.106 0.08 CID_980 | CID_980 | |
| 0.018 | 0.015 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.011 CID_980 | CID_980 | |
| 0.159 | 0.156 | 0.187 | Spasmolytic | 0.187 0.131 CID_980 | CID_980 | |
| 0.051 | 0.048 | 0.061 | DNA helicase inhibitor | 0.061 0.027 CID_980 | CID_980 | |
| 0.035 | 0.033 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.03 | 0.028 | 0.04 | Glutamate (mGluR3) agonist | 0.04 0.01 CID_980 | CID_980 | |
| 0.053 | 0.05 | 0.071 | Sphingosine 1-phosphate receptor 3 antagonist | 0.071 0.025 CID_980 | CID_980 | |
| 0.046 | 0.044 | 0.051 | Squalene epoxidase inhibitor | 0.051 0.032 CID_980 | CID_980 | |
| 0.058 | 0.056 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 CID_980 | CID_980 | |
| 0.014 | 0.013 | 0.019 | Purinergic P2Y1 agonist | 0.019 0.007 CID_980 | CID_980 | |
| 0.048 | 0.047 | 0.052 | Vanilloid 2 antagonist | 0.052 0.036 CID_980 | CID_980 | |
| 0.014 | 0.013 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 CID_980 | CID_980 | |
| 0.038 | 0.037 | 0.038 | Leukocyte elastase inhibitor | |||
| 0.196 | 0.196 | 0.37 | Interleukin 2 agonist | 0.37 0.037 CID_980 | CID_980 | |
| 0.048 | 0.047 | 0.102 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.102 0.01 CID_980 | CID_980 | |
| 0.024 | 0.024 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_980 | CID_980 | |
| 0.035 | 0.036 | 0.06 | CDK5/p25 inhibitor | 0.06 0.015 CID_980 | CID_980 | |
| 0.037 | 0.038 | 0.038 | VCAM-1 antagonist | 0.038 0.032 CID_980 | CID_980 | |
| 0.014 | 0.015 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.017 0.006 CID_980 | CID_980 | |
| 0.077 | 0.078 | 0.108 | CC chemokine 5 receptor agonist | 0.108 0.015 CID_980 | CID_980 | |
| 0.037 | 0.038 | 0.038 | VCAM antagonist | 0.038 0.032 CID_980 | CID_980 | |
| 0.009 | 0.01 | 0.015 | Thromboxane agonist | 0.015 0.005 CID_980 | CID_980 | |
| 0.037 | 0.04 | 0.052 | CF transmembrane conductance regulator antagonist | 0.052 0.007 CID_980 | CID_980 | |
| 0.036 | 0.038 | 0.056 | Carbonic anhydrase IV inhibitor | 0.056 0.021 CID_980 | CID_980 | |
| 0.024 | 0.028 | 0.031 | CDK4/cyclin D3 inhibitor | 0.031 0.017 CID_980 | CID_980 | |
| 0.043 | 0.048 | 0.061 | Dopamine beta hydroxylase inhibitor | 0.061 0.014 CID_980 | CID_980 | |
| 0.149 | 0.155 | 0.259 | Immunostimulant | 0.259 0.093 CID_980 | CID_980 | |
| 0.039 | 0.045 | 0.044 | Adenylate cyclase 1 inhibitor | 0.044 0.034 CID_980 | CID_980 | |
| 0.019 | 0.025 | 0.061 | Kainate receptor 4 antagonist | 0.061 0.005 CID_980 | CID_980 | |
| 0.052 | 0.058 | 0.174 | HIV-1 integrase (3'-Processing) inhibitor | 0.174 0.011 CID_980 | CID_980 | |
| 0.033 | 0.04 | 0.097 | Dopamine D5 agonist | 0.097 0.004 CID_980 | CID_980 | |
| 0.028 | 0.035 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 CID_980 | CID_980 | |
| 0.013 | 0.02 | 0.032 | Kainate receptor 3 antagonist | 0.032 0.005 CID_980 | CID_980 | |
| 0.044 | 0.051 | 0.079 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 CID_980 | CID_980 | |
| 0.071 | 0.078 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_980 | CID_980 | |
| 0.077 | 0.084 | 0.177 | 5-Lipoxygenase inhibitor | 0.177 0.03 CID_980 | CID_980 | |
| 0.031 | 0.039 | 0.055 | Urate transporter 1 inhibitor | 0.055 0.016 CID_980 | CID_980 | |
| 0.02 | 0.028 | 0.024 | ICAM 1 antagonist | 0.024 0.014 CID_980 | CID_980 | |
| 0.031 | 0.04 | 0.048 | Toll-Like receptor 2 agonist | 0.048 0.025 CID_980 | CID_980 | |
| 0.041 | 0.05 | 0.124 | Aldose reductase inhibitor | 0.124 0.014 CID_980 | CID_980 | |
| 0.058 | 0.067 | 0.078 | Prostaglandin-E synthase inhibitor | 0.078 0.04 CID_980 | CID_980 | |
| 0.013 | 0.022 | 0.048 | Kainate receptor 1 antagonist | 0.048 0.005 CID_980 | CID_980 | |
| 0.017 | 0.028 | 0.024 | Prostaglandin H2 antagonist | 0.024 0.019 CID_980 | CID_980 | |
| 0.015 | 0.025 | 0.056 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.056 0.006 CID_980 | CID_980 | |
| 0.066 | 0.077 | 0.087 | Vanilloid 4 agonist | 0.087 0.03 CID_980 | CID_980 | |
| 0.014 | 0.026 | 0.023 | Human T-cell leukemia virus type I protease inhibitor | 0.023 0.013 CID_980 | CID_980 | |
| 0.048 | 0.062 | 0.06 | Alpha 2 adrenoreceptor agonist | 0.06 0.043 CID_980 | CID_980 | |
| 0.066 | 0.08 | 0.105 | Estrogen receptor alpha antagonist | 0.105 0.024 CID_980 | CID_980 | |
| 0.02 | 0.034 | 0.033 | Glutamate (mGluR1) agonist | 0.033 0.008 CID_980 | CID_980 | |
| 0.039 | 0.054 | 0.06 | Beta 2 adrenoreceptor antagonist | 0.06 0.024 CID_980 | CID_980 | |
| 0.023 | 0.039 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.018 CID_980 | CID_980 | |
| 0.032 | 0.048 | 0.095 | AMPA 4 receptor antagonist | 0.095 0.005 CID_980 | CID_980 | |
| 0.036 | 0.055 | 0.044 | CDK7/cyclin H inhibitor | 0.044 0.035 CID_980 | CID_980 | |
| 0.02 | 0.039 | 0.026 | LFA antagonist | 0.026 0.023 CID_980 | CID_980 | |
| 0.017 | 0.037 | 0.063 | AMPA 3 receptor antagonist | 0.063 0.005 CID_980 | CID_980 | |
| 0.028 | 0.048 | 0.068 | Estradiol 17 beta-dehydrogenase inhibitor | 0.068 0.017 CID_980 | CID_980 | |
| 0.012 | 0.032 | 0.041 | Kainate receptor 5 antagonist | 0.041 0.007 CID_980 | CID_980 | |
| 0.021 | 0.041 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 CID_980 | CID_980 | |
| 0.012 | 0.033 | 0.018 | Telomerase stimulant | 0.018 0.01 CID_980 | CID_980 | |
| 0.015 | 0.036 | 0.102 | AMPA 1 receptor antagonist | 0.102 0.005 CID_980 | CID_980 | |
| 0.051 | 0.074 | 0.06 | Caspase 9 inhibitor | 0.06 0.048 CID_980 | CID_980 | |
| 0.036 | 0.059 | 0.05 | Dihydroorotate dehydrogenase inhibitor | 0.05 0.037 CID_980 | CID_980 | |
| 0.003 | 0.028 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 CID_980 | CID_980 | |
| 0.048 | 0.072 | 0.071 | Heat shock protein 90 beta antagonist | 0.071 0.027 CID_980 | CID_980 | |
| 0.049 | 0.074 | 0.055 | Leukotriene C antagonist | 0.055 0.044 CID_980 | CID_980 | |
| 0.04 | 0.066 | 0.14 | HIV-1 integrase (Strand Transfer) inhibitor | 0.14 0.014 CID_980 | CID_980 | |
| 0.021 | 0.048 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.033 0.021 CID_980 | CID_980 | |
| 0.031 | 0.057 | 0.059 | Thromboxane A2 antagonist | 0.059 0.029 CID_980 | CID_980 | |
| 0.043 | 0.069 | 0.054 | Thromboxane synthase inhibitor | 0.054 0.038 CID_980 | CID_980 | |
| 0.065 | 0.091 | 0.08 | Sphingosine 1-phosphate receptor antagonist | 0.08 0.045 CID_980 | CID_980 | |
| 0.018 | 0.045 | 0.027 | Vanilloid 2 agonist | 0.027 0.014 CID_980 | CID_980 | |
| 0.009 | 0.036 | 0.023 | Thyroid hormone alpha antagonist | 0.023 0.006 CID_980 | CID_980 | |
| 0.022 | 0.05 | 0.071 | Nicotinic acid receptor agonist | 0.071 0.008 CID_980 | CID_980 | |
| 0.029 | 0.056 | 0.066 | Phosphorylase inhibitor | 0.066 0.022 CID_980 | CID_980 | |
| 0.034 | 0.064 | 0.06 | Thromboxane antagonist | 0.06 0.032 CID_980 | CID_980 | |
| 0.012 | 0.043 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 CID_980 | CID_980 | |
| 0.054 | 0.085 | 0.133 | Topoisomerase II alpha inhibitor | 0.133 0.027 CID_980 | CID_980 | |
| 0.06 | 0.092 | 0.092 | Ornithine decarboxylase inhibitor | 0.092 0.053 CID_980 | CID_980 | |
| 0.015 | 0.051 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 CID_980 | CID_980 | |
| 0.014 | 0.051 | 0.039 | CXC chemokine 2 receptor antagonist | 0.039 0.008 CID_980 | CID_980 | |
| 0.113 | 0.15 | 0.163 | Nitric oxide antagonist | 0.163 0.085 CID_980 | CID_980 | |
| 0.075 | 0.112 | 0.102 | Electrolyte absorption antagonist | 0.102 0.055 CID_980 | CID_980 | |
| 0.04 | 0.079 | 0.059 | Sphingosine kinase 2 inhibitor | 0.059 0.033 CID_980 | CID_980 | |
| 0.067 | 0.107 | 0.156 | Topoisomerase I inhibitor | 0.156 0.039 CID_980 | CID_980 | |
| 0.04 | 0.083 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.035 CID_980 | CID_980 | |
| 0.016 | 0.059 | 0.028 | Thyroid hormone agonist | 0.028 0.014 CID_980 | CID_980 | |
| 0.044 | 0.088 | 0.169 | Phenylalanine 4-hydroxylase inhibitor | 0.169 0.009 CID_980 | CID_980 | |
| 0.053 | 0.098 | 0.069 | Prolactin release inhibitor | 0.069 0.024 CID_980 | CID_980 | |
| 0.052 | 0.098 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.026 CID_980 | CID_980 | |
| 0.013 | 0.059 | 0.074 | AMPA 2 receptor antagonist | 0.074 0.008 CID_980 | CID_980 | |
| 0.008 | 0.056 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.026 0.005 CID_980 | CID_980 | |
| 0.099 | 0.146 | 0.191 | Protein-tyrosine phosphatase inhibitor | 0.191 0.05 CID_980 | CID_980 | |
| 0.028 | 0.076 | 0.039 | Thymidine kinase inhibitor | 0.039 0.032 CID_980 | CID_980 | |
| 0.024 | 0.074 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 CID_980 | CID_980 | |
| 0.097 | 0.147 | 0.129 | Acetylcholine M1 receptor antagonist | 0.129 0.097 CID_980 | CID_980 | |
| 0.015 | 0.066 | 0.109 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.109 0.005 CID_980 | CID_980 | |
| 0.018 | 0.07 | 0.035 | ATP citrate lysase inhibitor | 0.035 0.018 CID_980 | CID_980 | |
| 0.018 | 0.07 | 0.028 | Cyclophilin A inhibitor | 0.028 0.026 CID_980 | CID_980 | |
| 0.069 | 0.122 | 0.105 | Protein kinase (CK2) alpha inhibitor | 0.105 0.072 CID_980 | CID_980 | |
| 0.047 | 0.101 | 0.092 | Aminopeptidase I inhibitor | 0.092 0.033 CID_980 | CID_980 | |
| 0.063 | 0.117 | 0.094 | Mediator release inhibitor | 0.094 0.077 CID_980 | CID_980 | |
| 0.034 | 0.088 | 0.051 | Topoisomerase II beta inhibitor | 0.051 0.031 CID_980 | CID_980 | |
| 0.021 | 0.076 | 0.031 | RNA-directed RNA polymerase inhibitor | 0.031 0.029 CID_980 | CID_980 | |
| 0.111 | 0.168 | 0.268 | Interleukin antagonist | 0.268 0.055 CID_980 | CID_980 | |
| 0.034 | 0.092 | 0.082 | CXC chemokine 1 receptor antagonist | 0.082 0.008 CID_980 | CID_980 | |
| 0.112 | 0.17 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.043 CID_980 | CID_980 | |
| 0.058 | 0.118 | 0.107 | Protein kinase (CK2) inhibitor | 0.107 0.058 CID_980 | CID_980 | |
| 0.008 | 0.072 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.014 CID_980 | CID_980 | |
| 0.065 | 0.134 | 0.171 | Topoisomerase II inhibitor | 0.171 0.041 CID_980 | CID_980 | |
| 0.047 | 0.117 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.054 CID_980 | CID_980 | |
| 0.019 | 0.088 | 0.048 | Oxytocin agonist | 0.048 0.025 CID_980 | CID_980 | |
| 0.033 | 0.108 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.03 CID_980 | CID_980 | |
| 0.07 | 0.147 | 0.198 | Glutamate receptor antagonist | 0.198 0.026 CID_980 | CID_980 | |
| 0.02 | 0.098 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | 0.061 0.034 CID_980 | CID_980 | |
| 0.04 | 0.119 | 0.093 | Neuraminidase (influenza) inhibitor | 0.093 0.019 CID_980 | CID_980 | |
| 0.018 | 0.101 | 0.061 | Ribonucleotide reductase inhibitor | 0.061 0.036 CID_980 | CID_980 | |
| 0.047 | 0.132 | 0.092 | Adrenaline agonist | 0.092 0.043 CID_980 | CID_980 | |
| 0.087 | 0.175 | 0.237 | Angiogenesis stimulant | 0.237 0.076 CID_980 | CID_980 | |
| 0.064 | 0.165 | 0.109 | MAP kinase kinase inhibitor | 0.109 0.086 CID_980 | CID_980 | |
| 0.05 | 0.153 | 0.122 | Protein-tyrosine phosphatase 1B inhibitor | 0.122 0.062 CID_980 | CID_980 | |
| 0.035 | 0.139 | 0.073 | CDC25B inhibitor | 0.073 0.035 CID_980 | CID_980 | |
| 0.056 | 0.162 | 0.235 | Chelator | 0.235 0.019 CID_980 | CID_980 | |
| 0.009 | 0.123 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.013 CID_980 | CID_980 | |
| 0.093 | 0.207 | 0.146 | Hepatoprotectant | 0.146 0.114 CID_980 | CID_980 | |
| 0.03 | 0.162 | 0.064 | Protein kinase C beta inhibitor | 0.064 0.061 CID_980 | CID_980 | |
| 0.031 | 0.165 | 0.06 | Cyclin B3 inhibitor | 0.06 0.057 CID_980 | CID_980 | |
| 0.02 | 0.154 | 0.074 | Neuraminidase inhibitor | 0.074 0.03 CID_980 | CID_980 | |
| 0.054 | 0.192 | 0.099 | Adenylate cyclase inhibitor | 0.099 0.086 CID_980 | CID_980 | |
| 0.009 | 0.156 | 0.166 | Estrogen agonist | 0.166 0.01 CID_980 | CID_980 | |
| 0.109 | 0.26 | 0.177 | Hypoglycemic | 0.177 0.138 CID_980 | CID_980 | |
| 0.045 | 0.201 | 0.12 | Uric acid excretion stimulant | 0.12 0.038 CID_980 | CID_980 | |
| 0.016 | 0.177 | 0.054 | Estrogen-related receptor beta antagonist | 0.054 0.005 CID_980 | CID_980 | |
| 0.032 | 0.194 | 0.067 | Histone deacetylase SIRT1 stimulant | 0.067 0.058 CID_980 | CID_980 | |
| 0.032 | 0.194 | 0.067 | Histone deacetylase stimulant | 0.067 0.058 CID_980 | CID_980 | |
| 0.103 | 0.267 | 0.17 | Death-associated protein kinase 2 inhibitor | 0.17 0.069 CID_980 | CID_980 | |
| 0.032 | 0.208 | 0.069 | CDC25A inhibitor | 0.069 0.059 CID_980 | CID_980 | |
| 0.046 | 0.227 | 0.267 | Estrogen receptor beta antagonist | 0.267 0.006 CID_980 | CID_980 | |
| 0.054 | 0.255 | 0.26 | Estrogen antagonist | 0.26 0.008 CID_980 | CID_980 | |
| 0.03 | 0.275 | 0.053 | Adenine nucleotide translocase inhibitor | 0.053 0.046 CID_980 | CID_980 | |
| 0.004 | 0.252 | 0.139 | Estrogen receptor beta agonist | 0.139 0.008 CID_980 | CID_980 | |
| 0.039 | 0.306 | 0.116 | DNA polymerase I inhibitor | 0.116 0.071 CID_980 | CID_980 | |
| 0.023 | 0.325 | 0.095 | HIV-1 integrase inhibitor | 0.095 0.028 CID_980 | CID_980 | |
| 0.003 | 0.308 | 0.089 | Estrogen receptor alpha agonist | 0.089 0.01 CID_980 | CID_980 | |
| 0.073 | 0.38 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | 0.126 0.067 CID_980 | CID_980 | |
| 0.093 | 0.411 | 0.273 | Sodium/bile acid cotransporter inhibitor | 0.273 0.105 CID_980 | CID_980 | |
| 0.028 | 0.371 | 0.085 | Opioid kappa receptor antagonist | 0.085 0.051 CID_980 | CID_980 | |
| 0.009 | 0.371 | 0.059 | NMDA 2B receptor antagonist | 0.059 0.032 CID_980 | CID_980 | |
| 0.006 | 0.478 | 0.061 | Opioid delta receptor antagonist | 0.061 0.045 CID_980 | CID_980 | |
| 0.017 | 0.508 | 0.087 | Opioid antagonist | 0.087 0.061 CID_980 | CID_980 | |
| 0.046 | 0.653 | 0.128 | MAP kinase kinase 4 inhibitor | 0.128 0.121 CID_980 | CID_980 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |